Literature DB >> 15553110

High resolution X-ray structure and potent anti-HIV activity of recombinant dianthin antiviral protein.

Igor V Kurinov1, Francis Rajamohan, Fatih M Uckun.   

Abstract

Dianthin antiviral protein (DAP) is a naturally occurring antiviral protein from the leaves of carnation (Dianthus caryophyllus) capable of depurinating HIV-1 RNA and inhibiting HIV-1 replication in human peripheral blood mononuclear cells. Escherichia coli-derived recombinant DAP (rDAP, amino acids 1-254) was purified to homogeneity for structural and functional studies. In the following paper the X-ray crystal structure of rDAP as well as its complexes with cyclic AMP and adenyl-guanosine (ApG) as substrate analogs at 1.7 A resolution are reported. Molecular modeling studies of the interactions of DAP and the structurally similar pokeweed antiviral protein (PAP) with a single-stranded RNA heptamer predicted a more potent anti-HIV activity for rDAP due to its unique surface topology and more favorable charge distribution in its 20 A-long RNA binding active center cleft. In accordance with the predictions of the modeling studies, rDAP was more potent than rPAP in depurinating HIV-1 RNA. To the knowledge of the authors, this is the first structural and functional characterization of recombinant DAP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15553110     DOI: 10.1055/s-0031-1297024

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  3 in total

1.  Structure of the Legionella Effector, lpg1496, Suggests a Role in Nucleotide Metabolism.

Authors:  Kathy Wong; Guennadi Kozlov; Yinglu Zhang; Kalle Gehring
Journal:  J Biol Chem       Date:  2015-08-20       Impact factor: 5.157

2.  Binding of adenine to Stx2, the protein toxin from Escherichia coli O157:H7.

Authors:  Marie E Fraser; Maia M Cherney; Paola Marcato; George L Mulvey; Glen D Armstrong; Michael N G James
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-06-26

Review 3.  Dianthin and Its Potential in Targeted Tumor Therapies.

Authors:  Hendrik Fuchs
Journal:  Toxins (Basel)       Date:  2019-10-11       Impact factor: 4.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.